P

Inventor

MAGGIO EDWARD T

US58 patents
⚠️ This page may combine multiple inventors who share the name “MAGGIO EDWARD T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MAGGIO EDWARD T

14 patents
US8226949B2Jul 24, 2012

Stabilizing alkylglycoside compositions and methods thereof

MAGGIO EDWARD T32 citations96
US8133863B2Mar 13, 2012

Stabilizing alkylglycoside compositions and methods thereof

MAGGIO EDWARD T38 citations96
US4397956AAug 9, 1983

Means for monitoring the status of control of ketoacidosis-prone diabetics

MAGGIO EDWARD T56 citations96
US8268791B2Sep 18, 2012

Alkylglycoside compositions for drug administration

MAGGIO EDWARD T36 citations93
US8084022B2Dec 27, 2011

Stabilizing alkylglycoside compositions and methods thereof

MAGGIO EDWARD T19 citations93
US8927497B2Jan 6, 2015

Absorption enhancers for intranasal administration

MAGGIO EDWARD T11 citations84
US8883728B2Nov 11, 2014

Intranasal administration of active agents to the central nervous system

MAGGIO EDWARD T5 citations84
US8846044B2Sep 30, 2014

Stabilizing alkylglycoside compositions and methods thereof

MAGGIO EDWARD T7 citations84
US8772231B2Jul 8, 2014

Stabilizing alkylglycoside compositions and methods thereof

MAGGIO EDWARD T12 citations84
US8642564B2Feb 4, 2014

Compositions for drug administration

MAGGIO EDWARD T11 citations84
US8440631B2May 14, 2013

Compositions for drug administration

MAGGIO EDWARD T7 citations84
US8173594B2May 8, 2012

Stabilizing alkylglycoside compositions and methods thereof

MAGGIO EDWARD T13 citations84
US8076290B2Dec 13, 2011

Stabilizing alkylglycoside compositions and methods thereof

MAGGIO EDWARD T12 citations84
US8551468B2Oct 8, 2013

Absorption enhancers for intranasal interferon administration

MAGGIO EDWARD T4 citations74

AEGIS THERAPEUTICS LLC

13 patents
US7998927B2Aug 16, 2011

Stabilizing alkylglycoside compositions and methods thereof

AEGIS THERAPEUTICS LLC38 citations96
US9642913B2May 9, 2017

Pharmaceutical composition including alkyl glycoside and an anti-seizure agent

AEGIS THERAPEUTICS LLC13 citations93
US10682414B2Jun 16, 2020

Intranasal epinephrine formulations and methods for the treatment of disease

AEGIS THERAPEUTICS LLC10 citations92
US11918655B2Mar 5, 2024

Intranasal epinephrine formulations and methods for the treatment of disease

AEGIS THERAPEUTICS LLC5 citations85
US11717571B2Aug 8, 2023

Intranasal epinephrine formulations and methods for the treatment of disease

AEGIS THERAPEUTICS LLC6 citations85
US11744895B2Sep 5, 2023

Intranasal epinephrine formulations and methods for the treatment of disease

AEGIS THERAPEUTICS LLC3 citations84
US11191838B2Dec 7, 2021

Intranasal epinephrine formulations and methods for the treatment of disease

AEGIS THERAPEUTICS LLC8 citations84
US11173209B2Nov 16, 2021

Compositions for drug administration

AEGIS THERAPEUTICS LLC6 citations84
US10576156B2Mar 3, 2020

Compositions for drug administration

AEGIS THERAPEUTICS LLC10 citations84
US10265402B2Apr 23, 2019

Absorption enhancers for drug administration

AEGIS THERAPEUTICS LLC13 citations84
US9446134B2Sep 20, 2016

Stabilizing alkylglycoside compositions and methods thereof

AEGIS THERAPEUTICS LLC4 citations84
US12324838B2Jun 10, 2025

Intranasal epinephrine formulations and methods for the treatment of disease

AEGIS THERAPEUTICS LLC3 citations74
US10046025B2Aug 14, 2018

Stabilizing alkylglycoside compositions and methods thereof

AEGIS THERAPEUTICS LLC3 citations73

SYNBIOTICS CORP

4 patents

NEURELIS INC

4 patents

SYVA CO

3 patents

SYVA

2 patents

AEGIS THERAPEUTICS INC

2 patents

CARTT STEVE

2 patents

QUEST DIAGNOSTICS INVEST INC

1 patent

INT DIAGNOSTIC TECH

1 patent

BAXTER TRAVENOL LAB

1 patent

HALE BIOPHARMA VENTURES LLC

1 patent

KARLOV VALERI I

1 patent

OPIANT PHARMACEUTICALS INC

1 patent

Showing the top 50 of 58 patents by PatentIndex Score.